[A case of metastatic XXXX arising from @entity356 resected after second-line chemotherapy].

@entity1 @entity11730 @entity96 @entity5 @entity3 @entity420 @entity356
A @entity1 in his 60s was diagnosed with @entity356 and underwent distal gastrectomy and D2 lymph node dissection. The histological diagnosis was @entity420 (T3, N1, StageIIB). He was treated with @entity11730 as adjuvant chemotherapy for 1 year. One year and 2 months after gastrectomy, a computed tomography(CT)scan revealed liver @entity3 (S8, 38mm). The @entity1 was diagnosed with liver @entity3 (refractory to @entity11730 ), and administered combination chemotherapy with irinotecan and cisplatin. After 4 courses of treatment, a CT scan detected a progressive @entity96 (55mm). Combination chemotherapy with docetaxel and @entity11730 was selected as second-line chemotherapy. After 6 courses of treatment, the @entity5 size reduced to 40mm in diameter, and no other @entity3 was detected. Nine months after the diagnosis of liver @entity3 , partial resection of the liver(S8)was performed. A pathological diagnosis of @entity420 was determined, and the pathological therapeutic effect was rated as Grade 1b. Combination chemotherapy with docetaxel and @entity11730 was found to be effective, and was thus administrated after the operation. There have been no signs of recurrence for 6 months after the operation. Surgery with perioperative chemotherapy can be an effective treatment for liver @entity3 from @entity356 .
